The cancer diagnostics company has gone into a trading halt following an adverse decision on reimbursement of its US bladder tests.
The hospitality group issued annual guidance as it rounds out the financial year.
Nikko Asset Management has dedicated a significant chunk of multiple portfolios to tech’s new frontier, eyeing long-term growth.
Billionaire Kerry Stokes' holdings company Seven has come out swinging against an report by Grant Samuels that said Boral has been undervalued in a takeover attempt.
The company says a disagreement has potential to prejudice an urgently needed capital raise to preserve company solvency.
The trade software business also says it plans to breakeven in FY25.
‘It was about time a New Zealand company explored opportunities in Australia,’ Bayleys managing director says.
Doug McKay and Rob McDonald follow chair Bruce Hassall out the door.
Few would disagree that the NZX needs more investors and deeper liquidity. Mark Peterson wants to make that happen and has enough optimism to defy the sceptics.
Director Meng Foon invited to resign after supporting controlling shareholder’s agenda.